1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. CATALYST PHARMACEUTICALS INC
Catalyst Pharmaceuticals Inc XNAS: CPRX

Catalyst Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Under Radar
about

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAP...

Read More
21.02 0.22 (1.06%)
37.03% Gain from 52W Low
1.3M
XNAS Volume

XNAS 29 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Catalyst Pharmaceuticals Inc is on 08 Aug 2025 for the purpose of Catalyst Pharmaceuticals Inc Second Quarter Earnings Conference Call for 2025 See details
Durability score
High Financial Strength
72.2 / 100
Valuation Score
Affordable Valuation
54.0 / 100
Momentum Score
Technically Neutral
47.9 / 100
Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM
Analyst Price Target
34
1Yr Price target upside is 63%
7 analysts

15

S

6

W

5

O

1

T

SWOT Analysis

Catalyst Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..